Literature DB >> 52425

Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

R L Dawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 52425      PMCID： PMC1538273     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  81 in total

1.  Experimental myositis in rats. II. The sensitivity of spleen cells to syngeneic muscle antigen.

Authors:  M M Esiri; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  The late onset myopathy. A clinicopathologic study of 131 patients.

Authors:  G M SHY
Journal:  World Neurol       Date:  1962-02

3.  Study of the autoimmune reaction in dermatomyositis.

Authors:  A C CURTIS; J H HECKAMAN; A H WHEELER
Journal:  JAMA       Date:  1961-11-11       Impact factor: 56.272

4.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

5.  Dermatomyositis in cancer: a possible etiological mechanism.

Authors:  J T GRACE; T L DAO
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

6.  Dermatomyositis and malignancy: a review of the literature.

Authors:  R C WILLIAMS
Journal:  Ann Intern Med       Date:  1959-05       Impact factor: 25.391

7.  Polymyositis and dermatomyositis.

Authors:  F M HOWARD; J E THOMAS
Journal:  Med Clin North Am       Date:  1960-07       Impact factor: 5.456

8.  Immune deficiencies, aplastic anemia and abnormalities of lymphoid tissue in thymoma.

Authors:  D Korn; A Gelderman; G Cage; D Nathanson; A J Strauss
Journal:  N Engl J Med       Date:  1967-06-15       Impact factor: 91.245

9.  Experimental autoimmune thymitis. An animal model of human myasthenia gravis.

Authors:  G Goldstein; S Whittingham
Journal:  Lancet       Date:  1966-08-06       Impact factor: 79.321

10.  Hereditary complement (C2) deficiency with dermatomyositis.

Authors:  J P Leddy; R C Griggs; M R Klemperer; M M Frank
Journal:  Am J Med       Date:  1975-01       Impact factor: 4.965
View more
  7 in total

1.  Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis.

Authors:  R L Dawkins; P J Zilko; E T Owen
Journal:  Br Med J       Date:  1975-12-27

2.  Polymyositis in Chagas's disease.

Authors:  W Cossermelli; H Friedman; E H Pastor; M R Nobre; A Manzione; M E Camargo; M Shiroma
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

3.  Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.

Authors:  W L Gross; J Krüger; U Gröschel-Stewart; H Friedrich; K Kunze
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

4.  Pathogenetic therapy of diseases of the nervous system and muscles with large doses of prednisolone on alternate days.

Authors:  B M Gekht; M I Kuzin; E A Kolomenskaya; E V Gnezditskaya; G S Zefirova; G V Ibragimova; I K Ippolitov; M G Kuralesin; I D Polykovskaya; D I Shagal
Journal:  Neurosci Behav Physiol       Date:  1981 Jul-Aug

5.  Lymphocyte subpopulations and surface membrane immunoglobulins in myasthenia gravis.

Authors:  G Landi; M Galli; G Ciboddo; G Colombo; G Scarlato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

6.  Experimental autoimmune myositis in SJL/J mice.

Authors:  N L Rosenberg; S P Ringel; B L Kotzin
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

7.  Impaired autologous mixed lymphocyte reaction with normal concanavalin A-induced suppression in adult polymyositis/dermatomyositis.

Authors:  R M Ransohoff; M M Dustoor
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.